Ocular survival after intra‐arterial chemotherapy for retinoblastoma improves with accrual of experience and programmatic evolution
SA Marasligiller, BK Williams, S Vadivelu… - Pediatric blood & …, 2023 - Wiley Online Library
Background Intra‐arterial chemotherapy (IAC) for the treatment of intraocular retinoblastoma
has gained recognition as a method to improve ocular salvage; however, there is a paucity …
has gained recognition as a method to improve ocular salvage; however, there is a paucity …
Urinary bladder retention secondary to intranasal administration of oxymetazoline “Afrin” for intra-arterial chemotherapy
T Smith, S Kritzmire, JG Tejada… - Interventional …, 2023 - journals.sagepub.com
Selective ophthalmic artery infusion of chemotherapy (SOAIC) has emerged as the standard
of care for retinoblastoma (RB). Intranasal oxymetazoline (INO), Afrin, is often …
of care for retinoblastoma (RB). Intranasal oxymetazoline (INO), Afrin, is often …
Three-Dimensional Ultrasound Imaging of Retinoblastoma and Its Correlation With Pathology
A Ramasubramanian, M Riemann… - … Surgery, Lasers and …, 2024 - journals.healio.com
Background and Objective: Monitoring the response of retinoblastoma to globe-salvaging
therapies is based on subjective assessments of changes determined by fundoscopy …
therapies is based on subjective assessments of changes determined by fundoscopy …
Intra-Arterial Chemotherapy for Retinoblastoma
SM Muns, VM Villegas, J Ramos-Acevedo… - Current Ophthalmology …, 2023 - Springer
Abstract Purpose of Review To review the surgical technique, pharmacotherapy,
contraindications, and outcomes of intra-arterial chemotherapy (IAC) in the treatment of …
contraindications, and outcomes of intra-arterial chemotherapy (IAC) in the treatment of …
Efficacy of a prolonged stability melphalan formulation for intra-arterial treatment of retinoblastoma
Background Melphalan, which is poorly soluble at room temperature, is widely used for the
treatment of retinoblastoma by selective ophthalmic artery infusion. Evomela, a propylene …
treatment of retinoblastoma by selective ophthalmic artery infusion. Evomela, a propylene …
Update of Retinoblastoma Management
CK Tarallo, T Abruzzo, A Ramasubramanian - Pediatric Ophthalmology, 2022 - Springer
Retinoblastoma is the most common pediatric ocular malignancy, with a majority of cases
being diagnosed before age of 5 years [1–3]. In recent studies, the incidence is …
being diagnosed before age of 5 years [1–3]. In recent studies, the incidence is …
[HTML][HTML] INTRA-ARTERIAL CHEMOTHERAPY TECHNIQUE
VM Villegas, JM Ramos-Acevedo, TG Murray - retinalphysician.com
An experienced neurointerventional radiologist or endovascular neurosurgeon typically
performs IAC for retinoblastoma under general anesthesia. The procedure can be performed …
performs IAC for retinoblastoma under general anesthesia. The procedure can be performed …
